|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Fresenius Medical Care AG (Germany), a leading provider of dialysis products and services. |
|---|---|
| Transferring Party | Renal Care Group, Inc., a dialysis service provider. |
| Sector | Medical Services |
| Date | March 31, 2005 |
| Analysis The $3.5 billion acquisition solidifies Fresenius' as the leader in dialysis services in the US and provides an excellent strategic and geographic fit. Also leverages the Fresenius infrastructure. In 2004, Renal Care Group's revenue was approx. US$1.35billion with an EBIT of US$254 million. Asof March 31, 2005, Renal Care Group owned more than 425 dialysis clinics andserved over 30,400 patients. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |